Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 31, 2024 16:01 ET | Source: Bionano Genomics

Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference

SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the...
June 17, 2024 16:05 ET | Source: Bionano Laboratories

Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis

American Medical Association issues Category I CPT code for the use of optical genome mapping in genome-wide analysis related to hematological malignancies
May 30, 2024 08:00 ET | Source: Bionano Genomics

Bionano Announces Robust Presence at Upcoming Cytogenetics Conferences ESHG and ACC with 39 Scientific Presentations and Posters Highlighting the Utility of the Optical Genome Mapping Workflow

Bionano announces a record 39 scientific presentations and posters highlighting optical genome mapping at two upcoming global cytogenetics conferences.
May 09, 2024 08:00 ET | Source: Bionano Genomics

Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis

Bionano announces significant advancements to its suite of computational tools for comprehensive cancer analysis.
May 01, 2024 08:00 ET | Source: Bionano Genomics

Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024

SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, May 8, 2024, at 4:30 p.m. Eastern...
April 30, 2024 16:05 ET | Source: Bionano Genomics

Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference

SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the RBC...
April 24, 2024 08:00 ET | Source: Bionano Genomics

Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing

Researchers used Cas9-directed Nanopore sequencing to validate structural variants detected by optical genome mapping in leukemia samples.
April 11, 2024 08:00 ET | Source: Bionano Genomics

Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing

Researchers used optical genome mapping in addition to whole genome sequencing in pediatric leukemia samples and identified additional structural variants.